SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA Pharmaceuticals Inc. (DUSA), Schiff Nutrition

   SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA
 Pharmaceuticals Inc. (DUSA), Schiff Nutrition International, Inc. (SHF) and
       The Warnaco Group, Inc. (WRC) and Class Action Against Questcor
                         Pharmaceuticals, Inc. (QCOR)

PR Newswire

NEW YORK, Nov. 8, 2012

NEW YORK, Nov. 8, 2012 /PRNewswire/ --

DUSA Pharmaceuticals Inc.
Levi & Korsinsky is investigating the Board of Directors of DUSA
Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty
and other violations of state law in connection with the sale of the Company
to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Schiff Nutrition International, Inc.
Levi & Korsinsky is investigating the Board of Directors of Schiff Nutrition
International, Inc. (NYSE: SHF) for possible breaches of fiduciary duty and
other violations of state law in connection with the sale of the Company to
Bayer HealthCare, LLC for $34 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/shiff-nutrition-international-shf, or call: 877-363-5972.

The Warnaco Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of The Warnaco Group,
Inc. (NYSE: WRC) for possible breaches of fiduciary duty and other violations
of state law in connection with the sale of the Company to PVH Corp. under
which shareholders will receive $51.75 in cash and 0.1822 of a PVH common
share per share.

Click here to learn more about the investigation
http://zlk.9nl.com/warnaco-group-wrc, or call: 877-363-5972.

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in
the USDC for the Central District of California on behalf of investors who
acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between
April 26, 2011 and September 21, 2012.

For more information, click here:
http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26,
2012  to request that the Court appoint you as lead plaintiff. 

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com